Latest stories on ETON
Eton Pharmaceuticals Has Stronger Earnings And A Little Valuation Cushion
Seeking Alpha52 · neutralanalyst
Eton Pharmaceuticals price target raised to $78 from $76 at Craig-Hallum
The Fly63 · neutralanalyst
Aquestive rises on licensing deal with Eton for antiseizure therapy
Seeking Alpha64 · neutralproduct/pr
Eton Pharmaceuticals Secures LIBERVANT U.S. Licensing Agreement
TipRanks63 · neutralproduct/pr
Eton Pharmaceuticals, Inc. (ETON) files 8-K
SEC 8-K50 · neutralm&a
Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. Licensing Agreement for LIBERVANT® (diazepam) Buccal Film
Business Insider64 · neutralproduct/pr
Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. Licensing Agreement for LIBERVANT® (diazepam) Buccal Film
GlobeNewswire64 · neutralproduct/pr
Eton Pharmaceuticals Relaunches IMPAVIDO for Rare Leishmaniasis Treatment
TipRanks59 · neutralproduct/pr
Eton Pharmaceuticals, Inc. (ETON) files 8-K
SEC 8-K50 · neutralgeneral
Eton Pharmaceuticals announces U.S. availability of Impavido
The Fly63 · neutralproduct/pr
Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO® (miltefosine) Capsules
GlobeNewswire63 · neutralproduct/pr
Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO® (miltefosine) Capsules
Business Insider63 · neutralproduct/pr
Eton Pharmaceuticals management to meet with Craig-Hallum
The Fly55 · neutralgeneral
Eton Pharmaceuticals participates in a conference call with Craig-Hallum
The Fly55 · neutralgeneral
Jim Cramer Explains Mad Money Caller How to Handle Eton Pharmaceuticals (ETON)
Yahoo Top63 · neutralanalyst
Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference
Business Insider56 · neutralgeneral
Lightning Round: Eton has had an exciting run, says Jim Cramer
CNBC63 · neutralanalyst
Eton Pharmaceuticals Earnings Call Signals Profitable Surge
TipRanks68 · bullishearnings
Eton Pharmaceuticals (ETON) Q2 2026 Earnings Call Transcript
Yahoo Finance73 · bullishearnings
Eton Pharmaceuticals (ETON) Q2 2026 Earnings Call Transcript
The Motley Fool73 · bullishearnings
Eton Pharmaceuticals participates in a conference call with Craig-Hallum
The Fly55 · neutralgeneral
Eton Pharmaceuticals sees FY26 revenue exceeding $145M consensus $121.32M
The Fly67 · bullishearnings
Eton Pharmaceuticals reports Q2 non-GAAP EPS 43c, consensus 19c
The Fly74 · bullishearnings
Eton Pharmaceuticals price target raised to $70 from $65 at H.C. Wainwright
The Fly63 · neutralanalyst
Eton Pharmaceuticals price target raised to $70 from $40 at B. Riley
The Fly65 · bullishanalyst